Ford, Janet H.
Stauffer, Virginia L.
McAllister, Peter
Akkala, Sreelatha
Sexson, Matthew
Ayer, David W.
Wang, Shufang
Funding for this research was provided by:
Eli Lilly and Company
Article History
Accepted: 4 September 2020
First Online: 17 September 2020
Change Date: 16 February 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s11136-020-02720-1
Compliance with ethical standards
:
: Janet Ford, Virginia Stauffer, Matthew Sexson, David Ayer, Shufang Wang are employees of Eli Lilly and Company, Indianapolis, IN, USA and hold company stock. Peter McAllister is an employee of New England Institute for Neurology and Headache, USA. He is an independent contractor and part of speaker bureaus at Teva Pharmaceuticals, Amgen and Allergan. Sreelatha Akkala is a full-time employee of Eli Lilly Services India Pvt. Ltd, India.
: Each participant provided consent for de-identified and aggregated reporting of research findings.
: This study was performed in full accordance with the US Health Insurance Portability and Accountability Act 1996.